Format

Send to:

Choose Destination
See comment in PubMed Commons below
PLoS One. 2012;7(10):e47655. doi: 10.1371/journal.pone.0047655. Epub 2012 Oct 29.

Neurocognition, insight and medication nonadherence in schizophrenia: a structural equation modeling approach.

Author information

  • 1Aix-Marseille University, EA 3279 - Public Health, Chronic Diseases and Quality of Life - Research Unit, Marseille, France. laurent.boyer@ap-hm.fr

Abstract

OBJECTIVE:

The aim of this study was to examine the complex relationships among neurocognition, insight and nonadherence in patients with schizophrenia.

METHODS:

DESIGN:

Cross-sectional study.

INCLUSION CRITERIA:

Diagnosis of schizophrenia according to the DSM-IV-TR criteria.

DATA COLLECTION:

Neurocognition was assessed using a global approach that addressed memory, attention, and executive functions; insight was analyzed using the multidimensional 'Scale to assess Unawareness of Mental Disorder;' and nonadherence was measured using the multidimensional 'Medication Adherence Rating Scale.'

ANALYSIS:

Structural equation modeling (SEM) was applied to examine the non-straightforward relationships among the following latent variables: neurocognition, 'awareness of positive symptoms' and 'negative symptoms', 'awareness of mental disorder' and nonadherence.

RESULTS:

One hundred and sixty-nine patients were enrolled. The final testing model showed good fit, with normed χ(2) = 1.67, RMSEA = 0.063, CFI = 0.94, and SRMR = 0.092. The SEM revealed significant associations between (1) neurocognition and 'awareness of symptoms,' (2) 'awareness of symptoms' and 'awareness of mental disorder' and (3) 'awareness of mental disorder' and nonadherence, mainly in the 'attitude toward taking medication' dimension. In contrast, there were no significant links between neurocognition and nonadherence, neurocognition and 'awareness of mental disorder,' and 'awareness of symptoms' and nonadherence.

CONCLUSIONS:

Our findings support the hypothesis that neurocognition influences 'awareness of symptoms,' which must be integrated into a higher level of insight (i.e., the 'awareness of mental disorder') to have an impact on nonadherence. These findings have important implications for the development of effective strategies to enhance medication adherence.

PMID:
23144705
[PubMed - indexed for MEDLINE]
PMCID:
PMC3483287
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk